SOLICITATION NOTICE
66 -- Assay Kits
- Notice Date
- 9/7/2019
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 334516
— Analytical Laboratory Instrument Manufacturing
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, 6001 Executive Boulevard, Room 4211, MSC 9559, Bethesda, Maryland, 20892-9559, United States
- ZIP Code
- 20892-9559
- Solicitation Number
- HHS-NIH-NIDA-OA-19-010243-CSS
- Point of Contact
- Debra C. Hawkins, Phone: 301-827-7751
- E-Mail Address
-
debra.hawkins@nih.gov
(debra.hawkins@nih.gov)
- Small Business Set-Aside
- N/A
- Description
- (i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. (ii) The solicitation number is HHS-NIH-NIDA-OA-19-010243-CSS and the solicitation is issued as a Request for Quotation (RFQ). This acquisition is for a commercial item or service and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13-Simplified Acquisition Procedures and FAR Part 12-Acquisition of Commercial Items. This acquisition is not expected to exceed the simplified acquisition threshold. The National Institute on Drug Abuse (NIDA), Office of Acquisition on behalf of the National Institute on Aging (NIA) intends to negotiate and award a purchase order for Assay Kits on a brand-name or equal basis. (iii) This solicitation incorporates the provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2019-05, effective August 13, 2019. (iv) The associated North American Industry Classification System (NAICS) code: 334516-Analytical Laboratory Instrument Manufacturing, Size Standard: 1,000 employees. (v) Assay Kits (vi) The National Institute of Aging (NIA) Intramural Research Program (IRP) requires Neurofilament light (NfL) assays for use in it's Healthy Aging in Neighborhoods of Diversity across the Life Span (HANDLS) research study. Neurofilament light (NfL) protein is expressed in brain neurons. NfL protein is released in significant quantity following axonal damage or neuronal degeneration. NfL is associated with traumatic brain injury, multiple sclerosis, frontotemporal dementia and other neurodegenerative diseases. There are disparities in the rates of brain dysfunction by race and poverty status. It is possible that NfL is one factor underlying disparities in the ways in which brain dysfunction manifests in different races and in adults with different socioeconomic statuses. NIH HANDLS researchers have examined various sources for disparities in cognitive decline including nutritional factors, genotypes, psychosocial stress, and neighborhood environments. Carrying these investigations further requires data on likely biomarkers of cognitive decline, of which NfL is a leading candidate. Little is known about the distribution of this marker in minority or socioeconomically diverse groups. It is possible that NfL may be an early marker of cognitive decline leading to dementia. The NIA required the Simoa 96-well plate assays and all necessary reagents to include: (1) Complete kit for running one 96-well plate of a Simoa 3-plex assay for human AB40, AB42, total Tau Advanced Quadrupole Technology combines high selectivity and efficiency of transfer for selected ions symmetrically across the isolation window; (2) Complete kit for 96-well plate of a Simoa assay for IL-6; (3) Complete kit for 96-well plate of a Simoa assay for NF-light; and (4) Complete assay kit for running one 96 well plate (or 96 tubes) of target analyte. Includes calibrator concentrate, calibrator diluent, beads detector, SBG, RGP, and sample diluent. Novel ETD HD-high dynamic range ETD provides significantly increased fragment ion coverage. The Simoa 96-well plate assays should be brand-name or equivalent to: (1) Product code: 103186, Product name: NF-light Simoa Assay Advantage Kit (Ref Cal)*, Product Description: Complete assay kit for running one 96 well plate (or 96 tubes) of target analyte. Includes reference calibrators, beads, detector, SBG, RGP, and sample diluent, Quantity: 32-each; (2) Product code: ACC1001, Product name: Accelerator Consumables Kit, Product Description: All consumables required to run one 96-well plate, including discs, tips, cuvettes, buffers, and sealing oil in the Accelerator Lab at Quanterix, Quantity: 32-each; and (3) Product code: 100835, Product name: Simoa Accelerator - 1 Plate Lab Service Fee, Product Description: Service charge for running one 96-well plate of any assay in the Accelerator. Includes data analysis, report, and data review with customer, Quantity: 32-each, manufactured by Quanterix, 113 Hartwell Avenue, Lexington, MA 02421, Telephone Number: (617) 301-9400, Representative: David Kulick, Email: dkulick@quanterix.com. (vii) Government's Anticipated Delivery: The period of performance is 1-year, from September 2019 through September 2020 After Receipt of Order (ARO). Delivery Point: FOB Destination. Delivery Location: National Institute on Aging, Baltimore, Maryland 21224. The successful offeror shall coordinate delivery arrangements with the customer prior to shipment. The Loading Dock hours are as follows: 8:00 am to 4:30 pm Eastern Time, Monday through Friday except on Federal holidays. All products delivered must contain a Packing Slip (with serial numbers as applicable). (viii) The provision at FAR clause 52.212-1, Instructions to Offerors - Commercial Items, applies to this acquisition. (ix) The provision at FAR clause 52.212-2, Evaluation - Commercial Items, applies to this acquisition. The Government will award a contract resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation will be most advantageous to the Government, price and other factors considered. The factors used to evaluate offers are the unique technical and performance capabilities of product and cost. Technical and past performance, when combined, are significantly more important than cost or price. (x) Offerors are advised to include a completed copy of the provision at FAR clause 52.212-3, Offeror Representations and Certifications - Commercial Items, with its offer. (xi) FAR clause at 52.212-4, Contract Terms and Conditions - Commercial Items, applies to this acquisition. (xii) FAR clause at 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders - Commercial Items, applies to this acquisition. (xiii) There are no additional contract requirement(s) or terms and conditions applicable to this acquisition. (xiv) Defense Priorities and Allocations System (DPAS) and assigned rating, is not applicable to this solicitation. (xv) All quotations or offers are due 12:00 Noon, Eastern Time, on September 13, 2019, and must reference the solicitation number noted herein. Quotations or offers must be submitted electronically to the contact person identified herein at debra.hawkins@nih.gov. Fax responses will not be accepted. (xvi) For information regarding this solicitation contact: Debra C. Hawkins Contractor, Acquisition Policy Analyst II, at 301-827-7751.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/NIDA-01/HHS-NIH-NIDA-OA-19-010243-CSS /listing.html)
- Place of Performance
- Address: National Institute on Aging, Baltimore, Maryland, 21224, United States
- Zip Code: 21224
- Zip Code: 21224
- Record
- SN05435446-W 20190909/190907230041-98b15e1cb987cc84baad27b5777ca9f7 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |